Cofactor Genomics ImmunoPrism®
Outside ImmunoPrism, there is no complete solution on the market today that characterizes the tumor microenvironment and generates multidimensional biomarkers from RNA data generated in your own laboratory, at a trusted CRO, or in Cofactor’s clinical laboratory. Even for difficult-to-measure cell types, such as M1 and M2 macrophages, the ImmunoPrism assay shows high sensitivity and specificity comparable to flow cytometry. The assay takes a new approach to immune cell characterization – leveraging targeted RNA sequencing and a database of immune Health Expression Models. Requiring only minimal solid tumor tissue, including low-input FFPE samples, clinical cohorts (such as responders and non-responders to therapy) are used to generate a machine-learning optimized multidimensional biomarker, with full statistical analysis summarized in the ImmunoPrism Biomarker Report:
https://cofactorgenomics.com/immunoprism-3-0-report-download
